Get started
Author

Anne Marijne Heeren

Observed names: A M Heeren, A Marijne Heeren, A. Heeren, A. M. Heeren, A. Marijne Heeren, A.Marijne Heeren, Heeren, A.M., M Heeren, Marijne Heeren
Observed institutions: Leiden University, Leiden University Medical Center, Amsterdam Neuroscience, Centrum voor Gynaecologische Oncologie Amsterdam, Amsterdam University Medical Centers, Neurology, Inc, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0000-0002-4158-6058
Observed ORCID: 0000-0002-4158-6058
OpenAlex ID: A5062581256
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
2016 · A Marijne Heeren, Simone Punt, et al. · Modern Pathology · 310
PDF
High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer
2014 · A. Marijne Heeren, Bas D. Koster, et al. · Cancer Immunology Research · 114
The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma
2018 · Sarah Rosanne Ottenhof, Rosa Sanne Djajadiningrat, et al. · Frontiers in Immunology · 111
PDF
PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
2020 · Jossie Rotman, Leontine A. S. den Otter, et al. · Frontiers in Immunology · 109
PDF
Development of the follicular basement membrane during human gametogenesis and early folliculogenesis
2015 · A Marijne Heeren, Liesbeth van Iperen, et al. · BMC Developmental Biology · 95
PDF
Unlocking the therapeutic potential of primary tumor-draining lymph nodes
2019 · Jossie Rotman, Bas D. Koster, et al. · Cancer Immunology Immunotherapy · 79
PDF
Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
2016 · Debbie M. Ferns, A. Marijne Heeren, et al. · Journal for ImmunoTherapy of Cancer · 70
PDF
Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
2019 · A. Marijne Heeren, Iske F. van Luijk, et al. · Cancer Immunology Immunotherapy · 65
PDF
Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels
2019 · A. M. Heeren, J. Rotman, et al. · Journal for ImmunoTherapy of Cancer · 61
PDF
Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area
2015 · A. Marijne Heeren, Eline de Boer, et al. · Oncotarget · 48
PDF
Cancer immunophenotyping by seven‐colour multispectral imaging without tyramide signal amplification
2018 · Marieke E Ijsselsteijn, Thomas P Brouwer, et al. · The Journal of Pathology Clinical Research · 39
PDF
Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
2018 · A. Marijne Heeren, Ilse van Dijk, et al. · Frontiers in Immunology · 39
PDF
High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
2016 · John P. Veluchamy, A. Marijne Heeren, et al. · Cancer Immunology Immunotherapy · 36
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma
2020 · Jossie Rotman, A. Marijne Heeren, et al. · Clinical Cancer Research · 34
On the development of extragonadal and gonadal human germ cells
2016 · A. Marijne Heeren, Nannan He, et al. · Biology Open · 31
PDF
Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth
2021 · Anne Marijne Heeren, Jossie Rotman, et al. · Journal for ImmunoTherapy of Cancer · 29
CD14+macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?
2015 · A Marijne Heeren, Gemma G Kenter, et al. · OncoImmunology · 24
PDF
HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia
2017 · Sanne Samuels, A. Marijne Heeren, et al. · Cancer Immunology Immunotherapy · 19
Surgery versus corticosteroid injection for carpal tunnel syndrome (DISTRICTS): an open-label, multicentre, randomised controlled trial
2025 · Wijnand A C Palmbergen, Roy Beekman, et al. · The Lancet · 15
PDF
Meiotic wave adds extra asymmetry to the development of female chicken gonads
2015 · Ana de Melo Bernardo, A. Marijne Heeren, et al. · Molecular Reproduction and Development · 15
PDF
Abstract 3877: MPL-5821, a macrophage targeted ESMTM p38 MAPK inhibitor, inhibits the production of TLR agonist induced IL-10 whilst sparing T-cell functionality
2018 · David Moffat, Martin Perry, et al. · Cancer Research · 2
High and interrelated rates of CD14+PD-L1+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer
2014 · A. Marijne Heeren, Bas D. Koster, et al. · F1000Research · 1
Phase-1 trial of neoadjuvant durvalumab immunotherapy (DURVIT) delivered peritumorally in early-stage cervical cancer: safety and immune efficacy data
2026 · Marije Strikwerda, Jossie Rotman, et al. · International Journal of Gynecological Cancer
DISTRICTS trial: enhancing carpal tunnel syndrome treatment – Authors' reply
2026 · Camiel Verhamme, Wijnand A C Palmbergen, et al. · The Lancet
Optimale behandeling bij carpaletunnelsyndroom: eerst een corticosteroïdinjectie of direct een operatie?
2025 · Palmbergen, W.A.C., Heeren, A.M., et al. · Pure Amsterdam UMC
Works count: 49
Citation count: 1,344
H-index: 18
I10-index: 20
Year
Topic
Type